Lazard Asset Management’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,566
Closed -$112K 2619
2022
Q3
$112K Buy
+6,566
New +$103K ﹤0.01% 1428
2022
Q2
Sell
-1,940
Closed -$21K 2636
2022
Q1
$21K Sell
1,940
-13,501
-87% -$151K ﹤0.01% 2061
2021
Q4
$271K Buy
+15,441
New +$300K ﹤0.01% 1212
2021
Q1
Sell
-5,896
Closed -$257K 2081
2020
Q4
$257K Buy
+5,896
New +$201K ﹤0.01% 1066

Other funds holding ONEM

Lazard Asset Management's ONEM Position: Q4 2022 in Review

Lazard Asset Management sold out of 1Life Healthcare (ONEM) in Q4 2022, closing a stake of 6,566 shares — an estimated $112K sold.

Lazard Asset Management first reported a position in ONEM in Q4 2020 and held it in 4 quarters. The position peaked at $271K in Q4 2021. 230 funds tracked by Wall St. Rank hold ONEM as of Q4 2022.

  • Lazard Asset Management reported no remaining 1Life Healthcare position as of Q4 2022 after selling out during the quarter.
  • Lazard Asset Management sold 6,566 1Life Healthcare shares in Q4 2022, an estimated $112K.
  • Lazard Asset Management first reported a position in 1Life Healthcare in Q4 2020 and held it in 4 quarters.
  • Lazard Asset Management's 1Life Healthcare position peaked at $271K in Q4 2021.
  • 230 funds tracked by Wall St. Rank held 1Life Healthcare as of Q4 2022.

Based on Lazard Asset Management's 13F filing for Q4 2022, filed 15 Feb 2023.